Aug 14, 2020
Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results
Jun 08, 2020
Federal Government Announces New Pilot Program to Help Stop Illegal Availability of Unapproved Opioids Online
Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Jun 01, 2020
Braeburn Submits Request for Final Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
May 27, 2020
Centene Announces Winners Of OpiEnd Youth Challenge
May 11, 2020
Behavioral Health Group (BHG) Opens Facility in Colorado Springs
Apr 27, 2020
National Medical Director Dr. Peter Coleman Voted Top Addiction Doc
Apr 21, 2020
Coleman Addiction Medicine Opens New Office in Fair Lawn, NJ
Apr 16, 2020
SUBLOCADE® Long-Term Safety Data Published in Journal of Clinical Psychopharmacology
Apr 16, 2020
Groups Recover Together Transitions to Telemedicine to Support Individuals in Need of Effective Treatment for Opioid Addiction Amidst COVID-19 Pandemic
Apr 02, 2020
BAART Programs Opens Outpatient, Opioid Addiction Treatment Programs in Bremerton & Port Angeles, Washington
Mar 23, 2020
Patrick J. Kennedy Joins Kaden Health as a Board Observer
Mar 23, 2020
One-Year Outcomes of Real-World RECOVER(TM) Study Published in Journal of Addiction Medicine
Mar 18, 2020
Patrick J. Kennedy Joins Kaden Health as a Board Observer
Feb 27, 2020
Medscape Partners with CO*RE and Realizeit to Launch Adaptive Learning Program on Pain Management and Opioids
Feb 25, 2020
Medication Treatments Led to 80 Percent Lower Risk of Fatal Overdose for Patients with Opioid Use Disorder than Medication-free Treatments
Feb 25, 2020
Successful Opioid Recovery Program Receives $2.7 Million in State Funding to Help Participants Pay for Sober Housing
Feb 12, 2020
Asana Recovery Publishes Document on Opioid Alternatives
Feb 12, 2020
Worldwide Prevalence of Opioid Use Disorders, 2019-2029 - Quantify Patient Populations to Target the Development of Future Products, Pricing Strategies and Launch Plans
Jan 29, 2020
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations for Treatment of Pain